Revvity, Inc. (RVTY)
The price, the headline numbers and the latest news, in one place.
Revvity, Inc. (RVTY) Stock Price, Analysis & Data
| Bid | 119.5 |
| Market Cap | 14.4B |
| Revenue (ttm) | 2.91B |
| Net Income (ttm) | 237M |
| 1.07 | |
| 2.08 | |
| 62.16 | |
| 21.84 | |
| P/B (ttm) | 1.99 |
| P/S (ttm) | 4.93 |
| Earnings Date | Oct 26, 2026 |
| Ask | 147 |
| Volume | 1,631,779 |
| Avg. Volume (20D) | 1,454,927 |
| Open | 127.34 |
| Previous Close | 128.80 |
| Day's Range | 125.46 - 128.81 |
| 52-Week Range | 81.22 - 130.07 |
| Analyst | n/a |
| Price Target | 122 (-5.18%) |
| Dividends | $0.28 (0.22%) |
| Ex-Dividend Date | Oct 23, 2026 |
About RVTY
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its p...
Financial Performance
In 2025, Revvity's revenue was 2.86B, an increase of 3.67% compared to the previous year's 2.76B. Earnings were 241.2M, a decrease of -10.79%.
Financial StatementsAnalyst Forecast
According to 15 analyst ratings, the average rating for RVTY stock is "null". The 12-month stock price forecast is 122, which is downside of 5.18% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of n/a misses estimates by $0, with -100.00% YoY decline.
- EPS of 1.41 exceeds estimates by 0.19, with 19.49% YoY growth.
Analysts project revenue of ... Upgrade
